Description: Levitee Labs Inc. develops and sells mushroom extract nutraceuticals, and supplies and equipment for mushroom cultivation. It operates through two divisions, MONK-E and Sporeo. The MONK-E division produces mushroom-based nutraceutical supplements with a primary focus on mushroom extracts. The Sporeo division produces sterilized spawn and substrates for mushroom cultivation. The company was formerly known as Fibonacci Capital Corp. and changed its name to Levitee Labs Inc. in November 30, 2020. Levitee Labs Inc. was incorporated in 2019 and is based in Vancouver, Canada.
Home Page: www.leviteelabs.com
800 West Pender Street
Vancouver,
BC
V6C 1J8
Canada
Phone:
250-465-8640
Officers
| Name | Title |
|---|---|
| Mr. David Bentil | CEO & Director |
| Mr. Marc Momeni | Executive VP & Co-Founder |
| Mr. Pouya Farmand | Co-Founder |
| Mr. Mackenzie Osborne C.F.A. | Head of M&A, Co-Founder and Director |
| Maigul Wickham CPA | Chief Financial Officer |
| Dr. Fady Hannah-Shmouni FRCPC, M.D. | Chief Medical & Scientific Officer and President of Clinics |
| Olivia Belcher-Coward | Marketing & Communications Manager |
| Mr. Azim Qazi M.B.A. | Head of Ecommerce & Consumer Packaged Goods |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.0611 |
| Price-to-Sales TTM: | 0.0359 |
| IPO Date: | |
| Fiscal Year End: | September |
| Full Time Employees: | 0 |